CVC  Mitsui Global Investment

http://www.mitsui-global.com/





     Office Locations:

535 Middlefield Road, Suite 100
Menlo Park, CA 94025
Phone: 650-234-5000
Fax: 650-323-1516

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth
  • Seed


 

Industries:

  • Communications & Networking
  • Consumer Products & Services
  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Retail & Restaurant
  • Software & Internet

  •  

    Description:

    Mitsui & Co. Global Investment, Inc. is the venture capital arm of Mitsui & Co. Ltd. specializing in investments in seed stage to formation capital, late stage venture to growth capital, and early stage midsized companies. It seeks to invest in Medical Healthcare (pharmaceuticals, medical devices and medical related services), Cleantech (green technology and new energies), IT (internet technology/services, software and electronics) and Consumer Services (food service and retail). Currently, the firm is focused on IT, healthcare, and cleantech industries. MCVP currently manages over $280 million in capital, focusing on early stage investments in U.S., China, Korea and Japan. Mitsui Global Investments was founded in 2001 and is based in New York, with additional offices in Menlo Park, California and Tokyo, Japan.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Masaji Matsuoka Principal
    Masashi Kiyomine Investment Director
    Sanjay Pichaiah Investment Director
    Shin Kodera Managing Director
    Shinya Imai President & CEO

     

    Portfolio companies include:


      4Info
        web link


      Actimis Pharmaceuticals
        web link


      Anaeropharma Science
        web link


      ArmaGen Technologies
        web link


      Autotalks
        web link


      Axikin Pharmaceuticals
        web link


      BioAmber
        web link


      Boingo Wireless
        web link


      CLARA ONLINE
        web link


      ContinuumRx
        web link


      CounterTack
        web link


      Edison Pharmaceuticals
        web link


      Etonenet
        web link


      Hainan Hailing Chemipharma


      Infomart International
        web link


      Kaltura
        web link


      Kaminario
        web link


      Mo'Minis
        web link


      Mobeam
        web link


      On-chip Biotechnologies
        web link


      Ooptiscan Biomedical
        web link


      OpenX
        web link


      Pinnacle Engines
        web link


      Protein Simple
        web link


      Proterra
        web link


      QD Laser
        web link


      Redwood Systems
        web link


      Rive Technology
        web link


      Spire
        web link


      Symic Biomedical
        web link


      Virident
        web link


     

    Recent News:


      There is no recent news for Mitsui Global Investment.